Tech Company CollectionsBiotechnology Companies
List of Biotechnology Companies
or search all companiesSelect...
Select...
Loading...
Page 1 of NaN
Displaying companies
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven histo | San Francisco | CA | 10 - 50 | 2025 | $120,000,000 |
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lys | San Francisco | CA | 10 - 50 | 2025 | $200,000,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the str | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 10 - 50 | 2024 | $48,000,000 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 2 - 10 | 2024 | $100,000,000 |
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) spec | Wilmington | DE | 10 - 50 | 2024 | $5,500,000 |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 10 - 50 | 2024 | $400,000,000 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 5 - 10 | 2024 | $41,000,000 |
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 2 - 10 | 2024 | $92,000,000 |
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 1 - 10 | 2024 | $3,000,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on pro | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 10 - 50 | 2024 | $325,000,000 |
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 5 - 10 | 2024 | $370,000,000 |
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 100 | 2024 | $34,000,000 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 1 - 10 | 2024 | $500,000 |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free f | San Francisco | CA | 1 - 10 | 2024 | $30,000,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end | San Francisco | CA | 50 - 100 | 2024 | $1,000,000,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machi | Irvine | CA | 5 - 10 | 2024 | $3,000,000 |
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
Crop Diagnostix is a biotechnology company that uses RNA sequencing and AI for predictive agriculture. | San Diego | CA | 2 - 10 | 2023 | $3,577,993 |
Granza Bio is a company that developing cancer therapies based on human body's immune system. | San Francisco | CA | 2 - 10 | 2023 | $7,640,000 |
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to- | San Francisco | CA | 10 - 50 | 2023 | $245,000,000 |
Taxa is a synthetic microbiome company sculpting the skin microbiome using genetic engineering technologies such as CRISPR/spCas9. | San Francisco | CA | 2 - 10 | 2023 | $2,500,000 |
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services. | Somerville | MA | 1 - 10 | 2023 | $500,000 |
ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | San Francisco | CA | 1 - 10 | 2023 | $500,000 |
Avenue Biosciences is pioneering the future of biotechnology, with a mission to transform the development of protein biologics for healthcare advancements. Our cutting-edge, high-throughput engineering platform transforms the production of protein biologic | Palo Alto | CA | 10 - 50 | 2023 | $2,500,000 |
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies . | Los Angeles | CA | 2 - 10 | 2023 | $30,000,000 |
Shinobi Therapeutics focuses on creating hypoimmune CD8αβ iPS-T cells that work with the immune system to treat cancer and other diseases. The company utilizes advanced immune evasion technology to enhance the effectiveness and accessibility of cell therap | South San Francisco | CA | 10 - 50 | 2023 | $178,000,000 |
NeuroBionics is pioneering the future of precision bioelectronic medicine by inventing the next generation of implanted devices that will seamlessly interface with the human body. | Seattle | WA | 2 - 10 | 2023 | $6,000,000 |
EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design. The business predicts protein structures by combining biological data from DNA sequences, gene expression, and epigenetic states, allowing scientists to u | New York | NY | 10 - 50 | 2023 | $142,000,000 |
Amplifyer Bio is a biotechnology research company that develops technology of transformative potential for the liquid biopsy field. | Lexington | MA | 1 - 10 | 2023 | $7,078,494 |
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 1 - 10 | 2023 | |
We are Montara Therapeutics, a San Francisco-based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory | San Francisco | CA | 10 - 50 | 2023 | $16,000,011 |
Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health. | San Diego | CA | 50 - 200 | 2023 | $14,999,999 |
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and | Chapel Hill | NC | 2 - 10 | 2023 | $11,000,000 |
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, | Fremont | CA | 20 - 50 | 2023 | $165,000,000 |
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages. | Boston | MA | 2 - 10 | 2023 | $5,200,000 |
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolo | Brookline | MA | 2 - 10 | 2023 | $20,000,000 |
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch | Bedford | MA | 10 - 50 | 2023 | $20,000,000 |
Biostate AI develops generative AI that benefit all human health. | Palo Alto | CA | 10 - 50 | 2023 | $4,000,000 |
Peregrine Health is a healthcare company formed by Integrative Life Network (ILN) and Integrative Health Centers. | Nashville | TN | 200 - 500 | 2023 | $8,514,671 |
Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. | New York | NY | 2 - 10 | 2023 | $5,100,000 |
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites | Cambridge | MA | 50 - 100 | 2023 | $30,877,444 |
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 20 - 100 | 2023 | $360,000,000 |
Velorum Therapeutics produces powerful cancer treatments that starve tumors. | South San Francisco | CA | 1 - 10 | 2023 | $500,000 |
Mach5 Therapeutics is a biotechnology company. | Atlanta | GA | 1 - 100 | 2023 | $4,175,000 |
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors. | American Fork | UT | 1 - 10 | 2023 | $500,000 |
Pranax is a software company currently based in Pinehurst, Texas, United States. It has been founded in 2023. | Pinehurst | TX | 2 - 10 | 2023 | $10,000,000 |
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. Transparency, accountability, and accuracy are essential to what makes us a reliable partner for process and analytical developmen | Gainesville | FL | 20 - 50 | 2023 | $36,000,000 |
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer | New York | NY | 5 - 10 | 2022 | $30,000,000 |
Developing extended-release PLG drug formulations takes $10M+ and 5-10 years. We enable drug manufacturers and CROs to shorten formulation discovery time by 30-50% by utilizing our automation and machine learning platform. | Woodland | CA | 5 - 20 | 2022 | $4,500,000 |
Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients. | New York | NY | 2 - 10 | 2022 | $500,000 |
TorMagnus Pharmaceuticals combines graph theory and network medicine approaches to use AI to aid in the identification of novel drug treatments. The immediate focus is on identifying targets for Parkinson's disease. | San Francisco | CA | 2 - 10 | 2022 | $500,000 |
Forward Therapeutics is a biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders. Forward Therapeutics is advancing a pipeline of novel, next-generation small molecule immune therapies. | Palm Beach Gardens | FL | 2 - 10 | 2022 | $50,000,000 |
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022. | Plymouth | MA | 20 - 50 | 2022 | $242,000,000 |
Bluestem Biosciences, Inc., is designing biology with the end in mind, to enable existing infrastructure in the Midwest for industrialized synthetic biology. We are leveraging digital biology to facilitate the discovery of biomanufacturing, focused on the | Omaha | NE | 5 - 20 | 2022 | $10,199,722 |
Bayspair Inc., a Delaware c-corporation, is a startup research and development life science/biotechnology company offering the most flexible genome editing solution in various fields such as agriculture, therapeutics and drug discovery. | Mountain View | CA | 1 - 10 | 2022 | $3,514,000 |
Sunstone Therapies focuses on the research and commercial delivery of psychedelic therapies for cancer patients. The company was founded in 2022 and is headquartered in Rockville, Maryland. | Rockville | MD | 10 - 50 | 2022 | $8,494,991 |
Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides which lies in its automated process of designing, synthesizing, and testing at an unprecedented scale. | Berkeley | CA | 10 - 50 | 2022 | $12,000,000 |
Mekanistic Therapeutics focuse on the development of cancer therapeutics. | Ann Arbor | MI | 5 - 10 | 2022 | |
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. | San Francisco | CA | 20 - 50 | 2022 | $47,000,000 |
Eugit Therapeutics is a therapeutics company that is working to create immunotherapies for the treatment of prostate, ovarian, and breast malignancies. Their gene engineering strategy begins with gamma delta T cells taken from healthy donors and develops a | San Carlos | CA | 2 - 10 | 2022 | $500,000 |
Aether Therapeutics is a biotechnology compound that develops pharmaceutical compound to treat addiction and withdrawal symptoms. | Austin | TX | 2 - 10 | 2022 | $4,078,010 |
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Its drug development engine delivers superior biologics optimized to create T-cell engagement by leveraging two technologies that power a pi | Philadelphia | PA | 2 - 10 | 2022 | $165,000,000 |
RyboDyn, Inc. is targeting the dark proteome to make new immunotherapies. We are unlocking and validating previously undiscovered, disease-specific targets that will impact the treatment of cancer and autoimmune diseases by driving a new wave of targeted t | San Diego | CA | 5 - 10 | 2022 | $4,000,000 |
Vetmab Biosciences is a veterinary company that currently operates in stealth mode. | San Francisco | CA | 2 - 10 | 2022 | |
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. | Littleton | CO | 10 - 50 | 2022 | $60,000,000 |
Marea Therapeutics is a clinical-stage biotechnology firm that uses the most recent advancements in human genetics to create first-in-class, next-generation medications for cardiometabolic illnesses. | San Francisco | CA | 5 - 10 | 2022 | $255,418,624 |
InduPro is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies. | Seattle | WA | 20 - 50 | 2022 | $85,000,000 |
BiomEdit is an innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, and engineered microbial medicines to address unmet needs in animal health. Our ambition is to create solutions to some of the most imp | Fishers | IN | 20 - 50 | 2022 | $48,500,000 |
Origin Endoscopy offers medical products to control the hemostatic effects of gastrointestinal bleeding during endoscopy procedures. | Englewood | CO | 2 - 10 | 2022 | $1,590,329 |
Izote Biosciences is a software company currently based in Berkeley, California, United States. It has been founded in 2022 by Victor Reyes-Umana. | Berkeley | CA | 2 - 10 | 2022 | $2,600,000 |
OverT Bio operates as a biotech company that provide cell therapy for cancers.. The company's cell therapies identify and develop novel genetic modifications that will help immune cells overcome barriers created by tumors and lead to effective and durable | New York | NY | 2 - 10 | 2022 | $16,120,000 |
Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles | Cambridge | MA | 10 - 50 | 2022 | $128,000,000 |
Cell BioEngines, Inc., is a clinical-stage biotech company focused on curing cancer by developing ”off-the-shelf” allogenic cell therapies. The company leverages its proprietary Stem-SPACE platform technology to produce clinical grade cells at scale. | New York | NY | 2 - 10 | 2022 | $1,375,000 |
Cisterna Biologics is a technology company that aims to solve the biotech industry's main challenges in developing mRNA-based therapeutics. Cisterna Biologics uses proprietary technologies to build the next generation of mRNA. | Carlsbad | CA | 1 - 10 | 2022 | $500,000 |
Vibe Bio is a community of patients, scientists, and partners committed to identifying, funding and developing promising treatments to rare diseases and empowering patient communities with unprecedented ownership over the process.Join us | Boston | MA | 10 - 50 | 2022 | $12,000,000 |
Amplexd Therapeutics focuses on the development of non-invasive, topical treatments aimed at addressing HPV-induced cervical dysplasia, a precursor to cervical cancer. The company's mission centers on providing accessible solutions to combat this public he | Gaithersburg | MD | 5 - 10 | 2022 | $2,000,000 |
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. Our platform creates candidate-ready compounds with unprecedented | Boston | MA | 5 - 20 | 2022 | $153,000,000 |
Arkea Bio develops technology to cut greenhouse gas (GHG) emissions from the agricultural industry. | Charlestown | MA | 10 - 20 | 2022 | $38,500,000 |
Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software | 10 - 20 | 2022 | $15,000,000 | ||
Systemic Bio is a 3D Systems company based in Houston, Texas, focused on the development of vascularized organ models made out of hydrogels and human cells to be used for drug discovery and development. | Houston | TX | 10 - 50 | 2022 | $15,000,000 |
Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabo | St. Louis | MO | 5 - 20 | 2022 | $11,973,835 |
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders. | San Francisco | CA | 10 - 50 | 2022 | $94,000,000 |
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is | Cambridge | MA | 20 - 50 | 2022 | $70,000,000 |
Visiox is a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options. | Tarrytown | NY | 5 - 10 | 2022 | |
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries | Cambridge | MA | 2 - 10 | 2022 | $6,999,999 |
Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently d | Cambridge | MA | 20 - 50 | 2022 | $50,000,000 |
Guardian Bio is centred on developing a personalised cell therapy based on dendritic cells. | Boston | MA | 2 - 10 | 2022 | $500,000 |
āshibio creates treatments for rare bone and connective tissue ailments, potentially preventing symptoms or slowing their course. | Brisbane | CA | 1 - 10 | 2022 | $40,000,000 |
Wild Microbes is a next-generation microbial platform that makes everything from plastics to proteins. They develop new microbial strains, making scaling sustainable products faster and cheaper than ever. | Cambridge | MA | 2 - 10 | 2022 | $3,300,000 |
Terragia Biofuel provides the technology to drive the next generation of biofuels. | Hanover | NH | 5 - 20 | 2022 | $6,000,000 |
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed | Redwood City | CA | 200 - 1,000 | 2022 | $3,000,000,000 |
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma. | Chapel Hill | NC | 10 - 50 | 2022 | $425,000,000 |
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs. | South San Francisco | CA | 5 - 20 | 2022 | $40,000,000 |
Noriware created a seaweed-based packaging film that is entirely composed of natural materials. The raw material seaweed's growth has a negative carbon footprint, with the final product being home-compostable in a revolutionary time frame and thus leaving | Sweden | SC | 2 - 10 | 2022 | 1116135 CHF |
Septerna's mission is to make the promise of future GPCR medicines a reality for patients. | San Francisco | CA | 20 - 100 | 2022 | $250,000,000 |
Loading...
Everything You Need, One Platform.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Stay Ahead of the Curve
Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.